Fecal calprotectin as an alternative to ulcerative colitis endoscopic index of severity to predict the response to corticosteroids of acute severe ulcerative colitis: A prospective observational study.
暂无分享,去创建一个
Chenyan Zhao | Tenghui Zhang | Weiming Zhu | Zhen Guo | Yi Li | J. Gong | C. Ding | Tingbin Xie | X. Dai | T. Lv | Chao Ding
[1] C. Baldaia,et al. The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitis. , 2016, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.
[2] H. Ogata,et al. Ulcerative colitis endoscopic index of severity is associated with long‐term prognosis in ulcerative colitis patients treated with infliximab , 2016, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.
[3] S. Osawa,et al. The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score. , 2016, Journal of Crohn's & colitis.
[4] W. Reinisch,et al. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease , 2016, Journal of Gastroenterology.
[5] O. Inatomi,et al. Prediction of clinical and endoscopic responses to anti-tumor necrosis factor-α antibodies in ulcerative colitis , 2016, Scandinavian journal of gastroenterology.
[6] P. Rutgeerts,et al. Agreement Between Rectosigmoidoscopy and Colonoscopy Analyses of Disease Activity and Healing in Patients With Ulcerative Colitis. , 2016, Gastroenterology.
[7] M. Silverberg,et al. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease , 2015, Inflammatory bowel diseases.
[8] E. di Giulio,et al. Disease Extension Matters in Endoscopic Scores: UCEIS Calculated as a Sum of the Single Colonic Segments Performed Better than Regular UCEIS in Outpatients with Ulcerative Colitis. , 2015, Journal of Crohn's & colitis.
[9] A. Bitton,et al. The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients. , 2014, Journal of Crohn's & colitis.
[10] S. Travis,et al. Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis. , 2013, Journal of Crohn's & colitis.
[11] M. Goenka,et al. Diagnosis of acute severe colitis. , 2014, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.
[12] Jianming Xu,et al. Early predictors of responses and clinical outcomes of corticosteroid treatment for severe ulcerative colitis , 2014, Scandinavian journal of gastroenterology.
[13] A. Schoepfer,et al. Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes , 2013, Inflammatory bowel diseases.
[14] S. Vermeire,et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. , 2012, Journal of Crohn's & colitis.
[15] A. Bellizzi,et al. MDCT assessment of ulcerative colitis: radiologic analysis with clinical, endoscopic, and pathologic correlation , 2012, Abdominal Imaging.
[16] D. Altman,et al. Translational Gastroenterology , 2011 .
[17] G. Porro,et al. Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[18] Fraser Cummings,et al. The pattern and outcome of acute severe colitis. , 2010, Journal of Crohn's & colitis.
[19] A. Griffiths,et al. Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response , 2010, Gut.
[20] B. Warren,et al. Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications , 2010, The British journal of surgery.
[21] Malfertheiner,et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. , 2010, Inflammatory bowel diseases.
[22] A. Hara,et al. Evaluation of colitis: usefulness of CT enterography technique , 2009, Emergency Radiology.
[23] S. Engum,et al. Steroids and poor nutrition are associated with infectious wound complications in children undergoing first stage procedures for ulcerative colitis. , 2008, Surgery.
[24] M. Vatn,et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. , 2007, Gastroenterology.
[25] T. Chattopadhyay,et al. Outcome following emergency surgery for refractory severe ulcerative colitis in a tertiary care centre in India , 2005, BMC gastroenterology.
[26] Å. Danielsson,et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. , 2005, Gastroenterology.
[27] R. Farrell,et al. Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[28] S. Travis,et al. Guidelines for the management of inflammatory bowel disease in adults , 2004, Gut.
[29] M. Fagerhol. Calprotectin, a faecal marker of organic gastrointestinal abnormality , 2000, The Lancet.
[30] R. Löfberg,et al. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis , 1998, European journal of gastroenterology & hepatology.
[31] D. Jewell,et al. Predicting outcome in severe ulcerative colitis. , 1996, Gut.
[32] S. Truelove,et al. The course and prognosis of ulcerative colitis , 1963, Gut.